Фото: Elizabeth Frantz / Reuters
The PDUFA also allows drug companies to pay additional, voluntary fees to the agency to help pay for additional staffers—a move that has seen some positive benefits in an expedited review process. Although the FDA has an agreement in place with titans of the industry outlining metrics and timelines of such a process, those companies—and the FDA itself—have never directly paid staffers for meeting or exceeding timelines, until now.
。PDF资料对此有专业解读
index = max(0, index - 1)
This change was provided thanks to the work of Mateusz Burzyński.
Go to technology